Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Venous Thromboembolism | 1 | 2022 | 195 | 0.590 |
Why?
|
| Retinal Diseases | 2 | 2019 | 142 | 0.540 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2024 | 108 | 0.520 |
Why?
|
| Genetic Therapy | 2 | 2016 | 713 | 0.500 |
Why?
|
| Macular Degeneration | 1 | 2016 | 86 | 0.440 |
Why?
|
| Diabetic Retinopathy | 2 | 2024 | 75 | 0.370 |
Why?
|
| Corneal Neovascularization | 1 | 2006 | 13 | 0.230 |
Why?
|
| Retinal Neovascularization | 1 | 2006 | 12 | 0.230 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 344 | 0.210 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 95 | 0.210 |
Why?
|
| Spatial Memory | 1 | 2022 | 29 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 137 | 0.180 |
Why?
|
| Thalamus | 1 | 2022 | 93 | 0.170 |
Why?
|
| Glaucoma | 1 | 2021 | 73 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 525 | 0.160 |
Why?
|
| Cataract | 1 | 2021 | 153 | 0.160 |
Why?
|
| Rats | 2 | 2022 | 3370 | 0.160 |
Why?
|
| Prefrontal Cortex | 1 | 2022 | 215 | 0.150 |
Why?
|
| Endophthalmitis | 1 | 2018 | 49 | 0.140 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2019 | 49 | 0.140 |
Why?
|
| Genetic Vectors | 2 | 2016 | 892 | 0.140 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 81 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 117 | 0.130 |
Why?
|
| Cataract Extraction | 1 | 2018 | 127 | 0.130 |
Why?
|
| Zika Virus | 1 | 2019 | 150 | 0.130 |
Why?
|
| Hippocampus | 1 | 2022 | 806 | 0.120 |
Why?
|
| Zika Virus Infection | 1 | 2019 | 173 | 0.120 |
Why?
|
| Animals | 7 | 2024 | 33912 | 0.120 |
Why?
|
| Choroidal Neovascularization | 1 | 2015 | 20 | 0.110 |
Why?
|
| Bevacizumab | 1 | 2015 | 59 | 0.110 |
Why?
|
| Placenta | 1 | 2019 | 504 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 514 | 0.100 |
Why?
|
| Milk, Human | 1 | 2015 | 321 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1129 | 0.090 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1990 | 34 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 1280 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 787 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1990 | 242 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2596 | 0.060 |
Why?
|
| Rats, Inbred BN | 1 | 2006 | 16 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 37 | 0.060 |
Why?
|
| Choroid | 1 | 2006 | 22 | 0.060 |
Why?
|
| Macaca fascicularis | 1 | 2006 | 84 | 0.060 |
Why?
|
| Electroretinography | 1 | 2006 | 96 | 0.060 |
Why?
|
| Iris | 1 | 2006 | 36 | 0.060 |
Why?
|
| Fluorescein Angiography | 1 | 2006 | 63 | 0.060 |
Why?
|
| Rabbits | 1 | 2006 | 575 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 358 | 0.050 |
Why?
|
| Chromogranins | 1 | 2023 | 30 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1205 | 0.050 |
Why?
|
| Retinal Vessels | 1 | 2023 | 48 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1105 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 490 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2006 | 849 | 0.040 |
Why?
|
| Gene Expression | 1 | 2006 | 1481 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2021 | 107 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 876 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 533 | 0.040 |
Why?
|
| Humans | 8 | 2024 | 131163 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 619 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 504 | 0.040 |
Why?
|
| Retina | 1 | 2023 | 425 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 570 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 523 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 110 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2465 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 18301 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 262 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1155 | 0.030 |
Why?
|
| Microcephaly | 1 | 2019 | 347 | 0.030 |
Why?
|
| Blood-Retinal Barrier | 1 | 2015 | 2 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 555 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 36 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1591 | 0.030 |
Why?
|
| Phenotype | 2 | 2019 | 4497 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 4697 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4738 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 325 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2015 | 240 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 986 | 0.020 |
Why?
|
| Male | 4 | 2019 | 64957 | 0.020 |
Why?
|
| Thioguanine | 1 | 1990 | 21 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 1990 | 32 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1990 | 66 | 0.020 |
Why?
|
| Gentamicins | 1 | 1990 | 88 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1990 | 242 | 0.020 |
Why?
|
| Introns | 1 | 1990 | 278 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1990 | 324 | 0.020 |
Why?
|
| Plasmids | 1 | 1990 | 449 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1990 | 235 | 0.020 |
Why?
|
| Glycols | 1 | 1988 | 6 | 0.020 |
Why?
|
| Self Mutilation | 1 | 1988 | 5 | 0.020 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1988 | 10 | 0.020 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1988 | 34 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1988 | 28 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1988 | 30 | 0.020 |
Why?
|
| Transfection | 1 | 1990 | 962 | 0.020 |
Why?
|
| Exons | 1 | 1990 | 759 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3763 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 653 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3175 | 0.020 |
Why?
|
| Base Sequence | 1 | 1990 | 2730 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 31282 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 7512 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3147 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 3464 | 0.010 |
Why?
|
| Cell Line | 1 | 1990 | 2552 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1988 | 218 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1990 | 2550 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 10103 | 0.010 |
Why?
|
| Female | 2 | 2019 | 70963 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20987 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21025 | 0.010 |
Why?
|
| Fluphenazine | 1 | 1988 | 4 | 0.000 |
Why?
|
| Carbidopa | 1 | 1988 | 18 | 0.000 |
Why?
|
| Catecholamines | 1 | 1988 | 49 | 0.000 |
Why?
|
| Tetrabenazine | 1 | 1988 | 38 | 0.000 |
Why?
|
| Levodopa | 1 | 1988 | 92 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1988 | 15110 | 0.000 |
Why?
|
| Child | 1 | 1988 | 26341 | 0.000 |
Why?
|